ESC Premium Access

Why is the baroreflex a relevant target for both resistant hypertension and heart failure?

Topic: CHF - Non pharmacological treatment
Organised by Charité Medical School, supported with an educational grant by CVRx

Congress Presentation

About the speaker

Professor Atul Pathak

The Princess Grace Hospital Centre, Monaco (Monaco)
14 presentations
0 follower

3 more presentations in this session

Welcome and introduction - Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension.

Speaker: Professor S. Anker (Berlin, DE) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Thumbnail

Resistant hypertension: stimulating the baroreflex when drugs have failed.

Speaker: Professor P. De Leeuw (Maastricht, NL)

Thumbnail

Heart failure with reduced ejection fraction and a narrow QRS: how can baroreflex activation therapy help?

Speaker: Professor C. Butter (Bernau bei Berlin, DE)

Thumbnail

Access the full session

Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension

Speakers: Professor A. Pathak, Professor S. Anker, Professor F. Zannad, Professor P. De Leeuw, Professor C. Butter
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk